- Steven WarmannProfessor, Dr., Med., Pediatric Surgery and Pediatric Urology, Hoppe-Seyler-Str. 3, 72076 Tuebingen, GermanyInterests: 56 publications, Not specified grants, Editor of Frontiers in BioscienceSpecial Issues and Topics in IMR Press journalsSpecial Issue in Hepatoblastoma
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 500 USD. Submitted manuscripts should be well formatted in good English.
Extended hepatic resection in advanced hepatoblastomaJoerg Fuchs, Guido Seitz, Rupert Handgretinger, Steven W WarmannFront. Biosci. (Elite Ed) 2012, 4(1), 462–469; https://doi.org/10.2741/e39117Downloads3Citations29Views
Hepatoblastoma throughout SIOPEL trials - clinical lessons learntPiotr CzaudernaFront. Biosci. (Elite Ed) 2012, 4(1), 470–479; https://doi.org/10.2741/e39246Downloads11Citations74Views
Molecular imaging and photodynamic therapy in hepatoblastomaGuido Seitz, Joerg Fuchs, Juergen F. Schaefer, Steven W. WarmannFront. Biosci. (Elite Ed) 2012, 4(1), 487–492; https://doi.org/10.2741/e39415Downloads2Citations36Views
Activation of Wnt and Myc signaling in hepatoblastomaStefano Cairo, Carolina Armengol, Marie Annick BuendiaFront. Biosci. (Elite Ed) 2012, 4(1), 480–486; https://doi.org/10.2741/e39331Downloads26Citations61Views
Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studiesBeate Haeberle, Dietrich von SchweinitzFront. Biosci. (Elite Ed) 2012, 4(1), 493–498; https://doi.org/10.2741/e39529Downloads23Citations60Views
Liver transplantation in the management of unresectable hepatoblastoma in childrenRebecka L. Meyers, Greg M. Tiao, Stephen P. Dunn, Max R. Langham Jr.Front. Biosci. (Elite Ed) 2012, 4(4), 1293–1302; https://doi.org/10.2741/e46043Downloads37Citations58Views
Treatment of hepatoblastoma: the North American cooperative group experienceMarcio H. Malogolowkin, Howard M. Katzenstein, Mark Krailo, Rebecka L. MeyersFront. Biosci. (Elite Ed) 2012, 4(5), 1717–1723; https://doi.org/10.2741/e49220Downloads19Citations34Views
Proteasome inhibition overcomes TRAIL resistance in human hepatoblastoma cellsSorin Armeanu-Ebinger, Joerg Fuchs, Julia Wenz, Guido Seitz, ... Steven W. WarmannFront. Biosci. (Elite Ed) 2012, 4(6), 2194–2202; https://doi.org/10.2741/e5365Downloads5Citations18Views
CD155 is involved in NK-cell mediated lysis of human hepatoblastoma in vitroMatthias Pfeiffer, Guido Seitz, Peter Ruck, Claudia Mueller, ... Steven WarmannFront. Biosci. (Elite Ed) 2011, 3(4), 1456–1466; https://doi.org/10.2741/E34614Downloads7Citations29Views